The global non-alcoholic steatohepatitis clinical trials market size is expected to be valued US$ 2.6 billion in 2022, according to Future Market Insights. On the other hand, a substantial expansion in the market is anticipated between 2022 and 2032, with a predicted growth rate of 7%, surpassing the historical increase. With a CAGR of 11.2% …
Tag Archives: Non-Alcoholic Steatohepatitis Clinical Trials Market size
Non-Alcoholic Steatohepatitis Clinical Trials Market is projected to increase at a CAGR of around 7% from 2022 to 2032
According to Future Market Insights’ Non-Alcoholic Steatohepatitis Clinical Trials Market global sales were stable at US$ 2.5 billion in 2021. The anticipated market growth from 2022 to 2032 is anticipated to be 7%, which is much greater than the increase in the past. With a CAGR of roughly 11.2% from 2022 to 2032, Phase 3 is …